Updating results

3465 results

Sort: Relevance | Date

LiMAx system for assessing the functional capacity of the liver (MIB168)

Advice on the use of LiMAx system for assessing the functional capacity of the liver to aid local decision making

Medtech innovation briefing Published January 2019

Path Finder for freezing of gait in people with Parkinson's disease (MIB170)

Advice on the use of Path Finder for freezing of gait in people with Parkinson’s disease to aid local decision-making

Medtech innovation briefing Published January 2019

StoneChecker for kidney stone evaluation (MIB171)

Advice on the use of StoneChecker for kidney stone evaluation to aid local decision making

Medtech innovation briefing Published February 2019

Opioid dependence: buprenorphine prolonged-release injection (Buvidal) (ES19)

Summary of the evidence on buprenorphine prolonged-release subcutaneous injection (Buvidal) for opioid dependence to inform local NHS

Evidence summary Published February 2019

Axonics sacral neuromodulation system for overactive bladder and faecal incontinence (MIB164)

Advice on the use of Axonics sacral neuromodulation system (SNM) for overactive bladder and faecal incontinence to aid local decision-making

Medtech innovation briefing Published December 2018

gammaCore for cluster headache (MIB162)

Advice on the use of gammaCore for cluster headaches to aid local decision-making

Medtech innovation briefing Published October 2018

Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy (ES20)

Summary of the evidence on doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy in women aged 18 years and older to inform local NHS

Evidence summary Published June 2019

Danis stent for acute oesophageal variceal bleeds (MIB185)

Advice on the use of Danis stent for acute oesophageal variceal bleeds to aid local decision making

Medtech innovation briefing Published June 2019

HemaClear for bloodless surgical field during limb surgery (MIB187)

Advice on the use of HemaClear for bloodless surgical field during limb surgery to aid local decision making

Medtech innovation briefing Published July 2019

Health app: Sleepio for adults with poor sleep (MIB129)

Advice on the use of the Sleepio health app to help adults with poor sleep improve sleep through cognitive behavioural therapy, to aid local decision-making

Medtech innovation briefing Published November 2017

Radiation dose monitoring software for medical imaging with ionising radiation (MIB127)

Advice on the use of radiation dose monitoring software for medical imaging with ionising radiation to aid local decision-making

Medtech innovation briefing Published October 2017

TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum (MIB134)

Advice on the use of the TYM smartphone otoscope (using Apple iOS device) for imaging/videoing the external ear canal and eardrum to aid local decision-making

Medtech innovation briefing Published January 2018

MammaTyper in vitro diagnostic test for determining breast cancer subtypes (MIB135)

Advice on the use of the MammaTyper in vitro diagnostic test for determining breast cancer subtypes to aid local decision-making

Medtech innovation briefing Published January 2018

IQoro for stroke-related dysphagia (MIB175)

Advice on the use of IQoro for stroke-related dysphagia to aid local decision making

Medtech innovation briefing Published March 2019

The PediGuard for placing pedicle screws in spinal surgery (MIB26)

Advice on the use of the PediGuard for placing pedicle screws in spinal surgery to aid local decision-making

Medtech innovation briefing Published March 2015

Xpert GBS test for the intrapartum detection of group B streptococcus (MIB28)

Advice on the use of the Xpert GBS test for the intrapartum detection of group B streptococcus (GBS) colonisation in pregnant women...

Medtech innovation briefing Published April 2015

Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab (ES1)

Summary of the evidence on rituximab for minimal change disease and focal segmental glomerulosclerosis to inform local NHS planning and decision-making

Evidence summary Published November 2016

The Space GlucoseControl system for managing blood‑glucose in critically ill patients in intensive care (MIB17)

Advice on the use of the Space GlucoseControl system for managing blood-glucose in critically ill patients in intensive care to aid local decision-making

Medtech innovation briefing Published December 2014

The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (MIB18)

Advice on the use of AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (CPR) to aid local decision-making

Medtech innovation briefing Published February 2015

Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumonia (MIB22)

Advice on the use of Shiley Endotracheal Tube with TaperGuard Cuff for patients at risk of ventilator-associated pneumonia to aid local decision-making

Medtech innovation briefing Published March 2015

Obese, overweight with risk factors: liraglutide (Saxenda) (ES14)

Summary of the evidence on liraglutide for managing obesity and overweight with risk factors in adults to inform local NHS planning and decision-making

Evidence summary Published June 2017

Neo Pedicle Screw System for spinal fusion surgery (MIB108)

Advice on the use of Neo Pedicle Screw System (single-use instruments, implantable screws and rods) for spinal fusion surgery to aid local decision-making

Medtech innovation briefing Published June 2017

VEST external stent for coronary artery bypass grafts (MIB115)

Advice on the use of VEST external stent for coronary artery bypass grafts to aid local decision-making

Medtech innovation briefing Published August 2017

FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care (MIB114)

Advice on the use of FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care to aid local decision-making

Medtech innovation briefing Published July 2017

Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)

Summary of the evidence on adjuvant bisphosphonates for preventing recurrence or improving survival in people with early breast cancer

Evidence summary Published July 2017

Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry (MIB113)

Advice on the use of the Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry to aid local-decision making

Medtech innovation briefing Published July 2017

Urethrotech UCD for difficult or failed catheterisation (MIB116)

Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making

Medtech innovation briefing Published August 2017

Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest (MIB112)

Advice on the use of Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest to aid local decision-making

Medtech innovation briefing Published July 2017

L-Dex U400 for lymphoedema after breast cancer treatment (MIB111)

Advice on the use of L-Dex U400 for lymphoedema (lymphedema) after breast cancer treatment to aid local decision-making

Medtech innovation briefing Published July 2017

SecurAcath for securing cerebrospinal fluid catheters (MIB107)

Advice on the use of SecurAcath for securing cerbrospinal fluid (CSF) drainage catheters to aid local decision-making

Medtech innovation briefing Published June 2017

Bindex for investigating suspected osteoporosis (MIB106)

Advice on the use of Bindex (portable pulse echo ultrasound device) for investigating suspected osteoporosis to aid local decision-making

Medtech innovation briefing Published May 2017

Preventing recurrence of Clostridium difficile infection: bezlotoxumab (ES13)

Summary of the evidence on bezlotoxumab for preventing the recurrence of Clostridium difficile (C difficile) infection

Evidence summary Published June 2017

Permacol for treating anal fistulae (MIB105)

Advice on the use of Permacol for treating anal fistulae (fistula) to aid local decision-making

Medtech innovation briefing Published May 2017

Non-Hodgkin's lymphoma: rituximab subcutaneous injection (ESNM46)

Summary of the evidence on rituximab subcutaneous injection for non-Hodgkin's lymphoma in adults to inform local NHS planning and decision-making

Evidence summary Published September 2014

Chronic obstructive pulmonary disease: beclometasone/formoterol (Fostair) (ESNM47)

Summary of the evidence on beclometasone/formoterol (Fostair) for treating chronic obstructive pulmonary disease (COPD)...

Evidence summary Published September 2014

Mitochondrial disorders in children: Co-enzyme Q10 (ES11)

Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making

Evidence summary Published March 2017

Hyperhidrosis: oxybutynin (ES10)

Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published March 2017

Non-cystic fibrosis bronchiectasis: colistimethate sodium (ESUOM25)

Summary of the evidence on colistimethate sodium (Colobreathe) for non-cystic fibrosis bronchiectasis to inform local NHS planning and decision-making

Evidence summary Published January 2014

Schizophrenia: omega-3 fatty acid medicines (ESUOM19)

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Evidence summary Published September 2013

Postural hypotension in adults: fludrocortisone (ESUOM20)

Summary of the evidence on fludrocortisone for treating postural hypotension in adults to inform local NHS planning and decision-making

Evidence summary Published October 2013

Chronic obstructive pulmonary disease: glycopyrronium bromide (ESNM9)

Summary of the evidence on glycopyrronium bromide for treating chronic obstructive pulmonary disease (COPD) to inform local NHS planning and decision-making

Evidence summary Published January 2013

Gastroparesis in adults: oral erythromycin (ESUOM13)

Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

Evidence summary Published June 2013

Hyperhidrosis: oral glycopyrronium bromide (ESUOM16)

Summary of the evidence on oral glycopyrronium bromide for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Bile acid malabsorption: colesevelam (ESUOM22)

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

Difficult-to-treat scabies: oral ivermectin (ESUOM29)

Summary of the evidence on oral ivermectin for treating difficult-to-treat scabies to inform local NHS planning and decision-making

Evidence summary Published March 2014

Interstitial cystitis: dimethyl sulfoxide bladder instillation (ESUOM26)

Summary of the evidence on dimethyl sulfoxide bladder instillation for treating interstitial cystitis to inform local NHS planning and decision-making

Evidence summary Published February 2014

Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream (ESNM68)

Summary of the evidence on ivermectin 10 mg/g cream for treating papulopustular rosacea to inform local NHS planning and decision-making

Evidence summary Published January 2016

Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)

Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 1 diabetes mellitus to inform local NHS planning and decision-making

Evidence summary Published October 2015

Facial erythema of rosacea: brimonidine tartrate gel (ESNM43)

Summary of the evidence on brimonidine tartrate gel for treating facial erythema of rosacea to inform local NHS planning and decision-making

Evidence summary Published July 2014

Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)

Summary of the evidence on canakinumab for treating systemic juvenile idiopathic arthritis (JIA) to inform local NHS planning and decision-making

Evidence summary Published March 2014